Silexion Therapeutics Corp · NASDAQ:SLXN
Mitchell P. Kopin reported a 9.99% stake in Silexion Therapeutics Corp (Schedule 13G)
Event Sep 11, 2025 · Filed Sep 17, 2025
Mitchell P. Kopin reported a 9.99% stake in Silexion Therapeutics Corp, 244,771 shares, as a passive investor on Sep 11, 2025. Filed Sep 17, 2025 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 244,771
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Mitchell P. Kopin | 9.99% | 244,771 |
| Daniel B. Asher | 9.99% | 244,771 |
| INTRACOASTAL CAPITAL, LLC | 9.99% | 244,771 |
Source
Related
- Silexion Therapeutics Corp
- Mitchell P. Kopin
- Silexion Therapeutics Corp shareholders
- Schedule 13G · Mitchell P. Kopin · Aug 18, 2026
- Schedule 13G/A · Mitchell P. Kopin · Feb 13, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Sep 28, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Aug 19, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Jun 23, 2026
- Form 4 · Shirvan Mitchell · Jun 8, 2026
- Form 4 · Horenshtein Hadar Mirit · Jun 8, 2026